Public preferences on written informed consent for low-risk pragmatic clinical trials in Spain

Author:

Dal-Ré Rafael12,Carcas Antonio J.3,Carné Xavier245,Wendler David6

Affiliation:

1. Clinical Research, BUC (Biosciences UAM+CSIC) Program, International Campus of Excellence; Universidad Autónoma de Madrid, Ciudad Universitaria de Cantoblanco; Einstein 3 28049 Madrid Spain

2. Chair on Bioethics ‘Grifols Foundation’; University of Vic-Central University of Catalonia; Miquel Martí i Pol 1, Campus Miramarges 08500 Vic Barcelona Spain

3. Clinical Pharmacology Department; La Paz University Hospital, IdiPaz, School of Medicine, Universidad Autónoma de Madrid; Paseo de la Castellana 261 28046 Madrid Spain

4. Clinical Pharmacology Department, Clínic Hospital, August Pi i Sunyer Biomedical Research Institute (IDIBAPS); Clinical Fundamentals Department; Universidad de Barcelona; Carrer de Villarroel 170 08036 Barcelona Spain

5. Chair on Bioethics ‘Grifols Foundation’; University of Vic-Central University of Catalonia; Miquel Martí i Pol 1, Campus Miramarges E-08500 Vic Barcelona Spain

6. Section on Research Ethics, Department of Bioethics; NIH Clinical Center; 10 Center Drive Bethesda MD 20814, USA

Funder

Grifols i Lucas Foundation, Barcelona, Spain

intramural research funds of the US NIH Clinical Center

Victor Grifols i Lucas Foundation

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3